A Phase 2, Randomized, Double-blind, Placebocontrolled, Parallel-group Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients with Moderate to Severe Hidradenitis Suppurativa (LOTUS).
CLINICAL TRIAL WITH MEDICINES
Clinical trial information
- Promoter: PAREXEL INTERNATIONAL (IRL) LIMITED
- Phase: II
- Execution start: 11/11/2024
- End of execution: 31/03/2026
- IP: ALEJANDRO MOLINA LEYVA